论文部分内容阅读
用大剂量尿激酶(UK)静脉溶栓(进口UK50万U静推5～15分钟,100万U静点30分钟或国产UK100万U静推5～15分种,100万U静点30分钟滴完)治疗30例发病6小时内急性心肌梗塞(AMI),根据临床冠脉再通指标观察再通率为96.7％(29/30),明显高于UK50～150万U/60～90分种静脉溶栓再通率(50％～55％),亦与rt-PA、SK加速溶栓治疗的结果相一致。无脑出血及严重内脏出血。大剂量UK静脉溶栓治疗AMI是一种安全有效的方法,值得进一步研究和推广。
High-dose urokinase (UK) intravenous thrombolysis (imported UK50 万 U static push 5 to 15 minutes, 1 million U static point 30 minutes or domestic UK100 million U static push 5 to 15 minutes, 1 million U static point 30 minutes Drip finished treatment of 30 cases of acute myocardial infarction within 6 hours of onset (AMI), according to clinical recanalization index observed rate of 96.7% (29/30), significantly higher than the UK 50 ~ 1.5 million U / 60 ~ 90 Intravenous thrombolysis recanalization rate (50% ~ 55%), also with rt-PA, SK accelerating thrombolysis results are consistent. No cerebral hemorrhage and severe visceral bleeding. High-dose UK intravenous thrombolytic therapy of AMI is a safe and effective method, it is worth further study and promotion.